Skip to main content

Paired Ends: Sep 1, 2009


Michael Snyder has moved from Yale University to Stanford University, where he has become chair of the Department of Genetics. He will also lead a new Center of Genomics and Personalized Medicine, which will bundle school and university efforts in genomics and their application to diagnosing and managing human disease.

At Yale, which he joined as a faculty member in 1986, Snyder was most recently a professor of biology and director of the Yale Center for Genomics and Proteomics. From 1998 until 2004, he was chair of the Department of Molecular, Cellular, and Developmental Biology. Snyder holds a PhD from the California Institute of Technology and did a postdoctoral fellowship at Stanford with Ron Davis in the Department of Biochemistry.

Jim McDonald has joined Oxford Nanopore Technologies as finance director. Previously, he was finance director of MediSense UK, which was later acquired by Abbott Laboratories. Prior to that, he held several positions at Arthur Andersen, both in London and in the US, and before that, he worked as a lawyer for a Denver law firm. He has a legal as well as a financial reporting background.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.